DURICEF Side Effects

6405390-6 | Asthenia, Balance Disorder, Dizziness, Dyspnoea, Feeling Abnormal, Hyperhidrosis, Palpitations
on Oct 16, 2009 Male patient from UNITED STATES , 79 years of age, weighting 215.0 lb, was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, dizziness (What is dizziness?), dyspnoea, feeling abnormal, hyperhidrosis, palpitations. Duricef dosage: 1 2 Daily Oral.

6384445-9 | Vomiting
Patient was taking Duricef (View Usage). Patient had the following side effects: vomiting on Sep 14, 2009 from BRAZIL Additional patient health information: Male patient , weighting 26.46 lb, . Duricef dosage: 100 Ml, Oral. Patient was hospitalized.

6329971-3 | Skin Test Positive
Adverse event was reported on Aug 10, 2009 by a Female patient taking Duricef (View Usage) (Dosage: 2g, Qd, Oral) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 60 years of age, After Duricef was administered, patient had the following side effects: skin test positive. During the same period patient was treated with CELESTENE /00008501/ (BETAMETHASONE) (View Celestene /00008501/ (betamethasone) Review and Celestene /00008501/ (betamethasone) Label ), TOPLEXIL (GUAIFENESIN, OXOMEMAZINE, PARACETAMOL, SODIUM BENZOATE) (View Toplexil (guaifenesin, Oxomemazine, Paracetamol, Sodium Benzoate) Review and Toplexil (guaifenesin, Oxomemazine, Paracetamol, Sodium Benzoate) Label ). Patient was hospitalized.

6134264-3 | Dyspnoea
on Mar 10, 2009 Female patient from UNITED STATES , 95 years of age, was diagnosed with c-reactive protein increased and was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Duricef dosage: Oral.


5989381-5 | Cardiac Tamponade, Collagen-vascular Disease, Pericarditis, Pneumonia, Streptococcal Infection
on Nov 19, 2008 Male patient from POLAND , child 12 years of age, was treated with Duricef (View Usage). Patient had the following side effects: cardiac tamponade, collagen-vascular disease, pericarditis, pneumonia (What is pneumonia?), streptococcal infection (What is streptococcal infection?). Duricef dosage: . Patient was hospitalized.

5972032-3 | Grand Mal Convulsion, Malaise
Patient was taking Duricef (View Usage). After Duricef was administered, patient had the following side effects: grand mal convulsion, malaise on Nov 06, 2008 from UNITED STATES Additional patient health information: Female patient , 18 years of age, was diagnosed with lymphadenopathy and. Duricef dosage: Cutaneous. Patient was hospitalized.

5946770-2 | Tubulointerstitial Nephritis
Adverse event was reported on Nov 07, 2008 by a Male patient taking Duricef (View Usage) (Dosage: ) was diagnosed with orthopedic procedure and. Location: UNITED STATES , child 11 years of age, weighting 200.2 lb, Patient experienced the following unwanted or unexpected effects: tubulointerstitial nephritis. Patient was hospitalized.

5766951-0 | Hepatic Function Abnormal, Pancreatitis, Toxic Epidermal Necrolysis
on May 23, 2008 Male patient from JAPAN , 29 years of age, was treated with Duricef (View Usage). Patient had the following side effects: hepatic function abnormal, pancreatitis, toxic epidermal necrolysis. Duricef dosage: Oral. During the same period patient was treated with COLD REMEDY / NON PYRINE COLD PREPARATION (NON BMS)() (Oral) (View Cold Remedy / Non-pyrine Cold Preparation (non-bms)() Review and Cold Remedy / Non-pyrine Cold Preparation (non-bms)() Label ), STOMACHIC AND DIGESTIVES (NON BMS)() (Oral) (View Stomachic And Digestives (non-bms)() Review and Stomachic And Digestives (non-bms)() Label ). Patient was hospitalized.

5698779-4 | Anosmia, Atrophy, Olfactory Nerve Disorder
on Mar 20, 2008 Female patient from POLAND , 78 years of age, was diagnosed with influenza and was treated with Duricef (View Usage). After Duricef was administered, patient had the following side effects: anosmia, atrophy, olfactory nerve disorder. Duricef dosage: 500 Mg, Bid, Oral. During the same period patient was treated with INHIBACE /00498401/ (CAPTOPRIL) (View Inhibace /00498401/ (captopril) Review and Inhibace /00498401/ (captopril) Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), CONCOR /00802602/ (BISOPROLOL FUMARATE) (View Concor /00802602/ (bisoprolol Fumarate) Review and Concor /00802602/ (bisoprolol Fumarate) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5689724-6 | Dyspnoea
Patient was taking Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea on Mar 14, 2008 from POLAND Additional patient health information: Male patient , 16 years of age, was diagnosed with upper respiratory tract inflammation and. Duricef dosage: 1000mg, Bid, Oral. During the same period patient was treated with MULTIVITAMIN /00831701/ (VITAMINS NOS) (View Multivitamin /00831701/ (vitamins Nos) Review and Multivitamin /00831701/ (vitamins Nos) Label ).

5643279-0 | Arthralgia, Hyperhidrosis, Inflammation, Productive Cough, Serum Sickness, Skin Exfoliation
Adverse event was reported on Feb 11, 2008 by a Male patient taking Duricef (View Usage) (Dosage: 1 G, Qd, Oral) was diagnosed with temperature intolerance, productive cough and. Location: UNITED STATES , 57 years of age, Patient had the following side effects: arthralgia, hyperhidrosis, inflammation, productive cough, serum sickness, skin exfoliation. During the same period patient was treated with AUGMENTIN (1.0 G, Qd, Oral) (View Augmentin Review and Augmentin Label ), VASTAREL (TRIMETAZIDINE HYDROCHLORIDE) (View Vastarel (trimetazidine Hydrochloride) Review and Vastarel (trimetazidine Hydrochloride) Label ), OMACOR (View Omacor Review and Omacor Label ), PLAVIX (View Plavix Review and Plavix Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), TENORMIN (View Tenormin Review and Tenormin Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), EFFEXOR (VENLAFAXIINE) (View Effexor (venlafaxiine) Review and Effexor (venlafaxiine) Label ). Patient was hospitalized.

5615374-3 | Pneumonia
on Jan 17, 2008 Female patient from BRAZIL , child 3 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Duricef (View Usage). After Duricef was administered, patient had the following side effects: pneumonia (What is pneumonia?). Duricef dosage: 1 Dose Every 12 Hours X 10 Days, Oral. During the same period patient was treated with PRELONE (PREDNISOLONE) (View Prelone (prednisolone) Review and Prelone (prednisolone) Label ). Patient was hospitalized.

5592628-0 | Asthenia, Nausea, Rash
on Jan 02, 2008 Female patient from UNITED STATES , 31 years of age, was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, nausea (What is nausea?), rash (What is rash?). Duricef dosage: Oral.

5485977-8 | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Dermatitis Exfoliative, Hepatic Function Abnormal, Lymphocyte Morphology Abnormal, Myalgia
Patient was taking Duricef (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, dermatitis exfoliative, hepatic function abnormal, lymphocyte morphology abnormal, myalgia on Sep 28, 2007 from INDONESIA Additional patient health information: Male patient , 51 years of age, . Duricef dosage: 500 Mg, Bid. Patient was hospitalized.

5423106-7 | Hepatic Function Abnormal, Pancreatitis, Toxic Epidermal Necrolysis
Adverse event was reported on Aug 09, 2007 by a Male patient taking Duricef (View Usage) (Dosage: Oral) . Location: JAPAN , 29 years of age, After Duricef was administered, patient had the following side effects: hepatic function abnormal, pancreatitis, toxic epidermal necrolysis. During the same period patient was treated with COLD REMEDY / NON PYRINE COLD PREPARATION (NON BMS) () (View Cold Remedy / Non-pyrine Cold Preparation (non-bms) () Review and Cold Remedy / Non-pyrine Cold Preparation (non-bms) () Label ), STOMACHIC AND DIGESTIVES (NON BMS) ( ) (View Stomachic And Digestives (non-bms) ( ) Review and Stomachic And Digestives (non-bms) ( ) Label ). Patient was hospitalized.

5369171-7 | Eyelid Oedema, Face Oedema, Lip Swelling, Stomatitis
on Jun 11, 2007 Male patient from FRANCE , child 9 years of age, was diagnosed with tonsillitis and was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: eyelid oedema, face oedema, lip swelling, stomatitis. Duricef dosage: Oral. During the same period patient was treated with SURGAM (TIAPROFENAC ACID) (Oral) (View Surgam (tiaprofenac Acid) Review and Surgam (tiaprofenac Acid) Label ). Patient was hospitalized.

5318793-8 | Cytolytic Hepatitis, Eosinophilia, Stevens-johnson Syndrome
on Apr 19, 2007 Female patient from FRANCE , 41 years of age, was diagnosed with tonsillitis and was treated with Duricef (View Usage). Patient had the following side effects: cytolytic hepatitis, eosinophilia, stevens-johnson syndrome. Duricef dosage: 1 G, Bid, Oral. During the same period patient was treated with CLARADOL /00020001 (PARACETAMOL) 1G (1 G, Tid, Oral) (View Claradol /00020001 (paracetamol) 1g Review and Claradol /00020001 (paracetamol) 1g Label ), RIBATRAN (CHYMOTRYPSIN, RIBONUCLEASE, TRYPSIN) (1 Dose, Tid, Oral) (View Ribatran (chymotrypsin, Ribonuclease, Trypsin) Review and Ribatran (chymotrypsin, Ribonuclease, Trypsin) Label ). Patient was hospitalized.

5296109-3 | Anaphylactic Shock, Nausea
Patient was taking Duricef (View Usage). After Duricef was administered, patient had the following side effects: anaphylactic shock, nausea (What is nausea?) on Mar 22, 2007 from FRANCE Additional patient health information: Male patient , 41 years of age, was diagnosed with pharyngolaryngeal pain and. Duricef dosage: 1 Single Dose, Oral. Patient was hospitalized.

5268304-0 | Epistaxis, Purpura, Type Iv Hypersensitivity Reaction
Adverse event was reported on Feb 26, 2007 by a Female patient taking Duricef (View Usage) (Dosage: 500mg Two Caps, Bid, Oral) was diagnosed with nasopharyngitis and. Location: FRANCE , 40 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis, purpura, type iv hypersensitivity reaction.

5248511-3 | Angioedema, Dyspnoea, Face Oedema, Feeling Abnormal, Local Swelling, Oedema Mouth, Pyrexia, Tongue Oedema, Urinary Retention
on Feb 06, 2007 Female patient from ESTONIA , 59 years of age, was diagnosed with ear infection (What is ear infection?) and was treated with Duricef (View Usage). Patient had the following side effects: angioedema, dyspnoea, face oedema, feeling abnormal, local swelling, oedema mouth, pyrexia, tongue oedema, urinary retention. Duricef dosage: 500 Mg, Bid, Oral.

5228290-6 | Abdominal Pain Upper, Chest Pain, Contraindication To Medical Treatment, Dyspnoea, Epistaxis, Vomiting
on Jan 31, 2007 Male patient from UNITED STATES , weighting 53.00 lb, was diagnosed with streptococcal infection (What is streptococcal infection?) and was treated with Duricef (View Usage). After Duricef was administered, patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), contraindication to medical treatment, dyspnoea, epistaxis, vomiting. Duricef dosage: 500mg 2x Day Po.

5226047-3 | Eye Excision, Eye Infection, Flushing, Thrombosis, Toxic Epidermal Necrolysis, Unevaluable Event
Patient was taking Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: eye excision, eye infection (What is eye infection?), flushing, thrombosis, toxic epidermal necrolysis, unevaluable event on Jan 12, 2007 from SWEDEN Additional patient health information: Female patient , 31 years of age, was diagnosed with nasopharyngeal disorder, pharyngeal oedema, pharyngolaryngeal pain and. Duricef dosage: Oral. During the same period patient was treated with IBUPROFEN (Oral) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5190737-1 | Arthralgia, Oral Soft Tissue Disorder, Pyrexia, Rash Maculo-papular
Adverse event was reported on Nov 30, 2006 by a Female patient taking Duricef (View Usage) (Dosage: ) . Location: FRANCE , child 6 years of age, weighting 44.09 lb, Patient had the following side effects: arthralgia, oral soft tissue disorder, pyrexia, rash maculo-papular. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5164851-0 | Diarrhoea Haemorrhagic
on Oct 27, 2006 Female patient from UNITED KINGDOM , 48 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Duricef (View Usage). After Duricef was administered, patient had the following side effects: diarrhoea haemorrhagic. Duricef dosage: 500 Mg, Bid, Oral. During the same period patient was treated with NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

5155457-8 | Swelling
on Oct 27, 2006 Female patient from UNITED STATES , 52 years of age, was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: swelling. Duricef dosage: 500 Mg, Bid, Oral. During the same period patient was treated with CALCIUM CARBONATE (CALCIUM CARBONATE) (View Calcium Carbonate (calcium Carbonate) Review and Calcium Carbonate (calcium Carbonate) Label ), PARAMAX (View Paramax Review and Paramax Label ), CODEINE PHOSPHATE (CODEINE PHOSPHATE) (View Codeine Phosphate (codeine Phosphate) Review and Codeine Phosphate (codeine Phosphate) Label ). Patient was hospitalized.

5154556-4 | Diarrhoea Haemorrhagic
Patient was taking Duricef (View Usage). Patient had the following side effects: diarrhoea haemorrhagic on Oct 27, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 48 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Duricef dosage: 500 Mg Oral. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ).

5041923-2 | Diarrhoea, Nausea, White Blood Cell Count Decreased
Adverse event was reported on Jun 15, 2006 by a Female patient taking Duricef (View Usage) (Dosage: 500 Mg, Oral) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 76 years of age, After Duricef was administered, patient had the following side effects: diarrhoea, nausea (What is nausea?), white blood cell count decreased. Patient was hospitalized.

4850464-4 | Oedema Peripheral, Rash Pruritic
on Dec 07, 2005 Male patient from UNITED STATES , 86 years of age, weighting 177.3 lb, was diagnosed with cellulitis (What is cellulitis?) and was treated with Duricef (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, rash pruritic. Duricef dosage: 500mg. During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), HYDOXYZINE (View Hydoxyzine Review and Hydoxyzine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

4849839-9 | Clostridial Infection, Diarrhoea Haemorrhagic
on Apr 14, 2005 Male patient from UNITED STATES , weighting 22.93 lb, was diagnosed with lymphadenitis and was treated with Duricef (View Usage). Patient had the following side effects: clostridial infection, diarrhoea haemorrhagic. Duricef dosage: 3 Ml, Bid, Oral. During the same period patient was treated with AUGMENTIN (CLAVULANATE POTASSIUM, AMOXICILLIN TRIHYDRATE) (View Augmentin (clavulanate Potassium, Amoxicillin Trihydrate) Review and Augmentin (clavulanate Potassium, Amoxicillin Trihydrate) Label ), OMNICEF (View Omnicef Review and Omnicef Label ).

4667448-1 | Clostridium Colitis
Patient was taking Duricef (View Usage). After Duricef was administered, patient had the following side effects: clostridium colitis on Apr 26, 2004 from Additional patient health information: Male patient , 67 years of age, . Duricef dosage: Oral. During the same period patient was treated with TEQUIN (Intravenous) (View Tequin Review and Tequin Label ), ANCEF (View Ancef Review and Ancef Label ), VANCOMYCIN (Iv Drip) (View Vancomycin Review and Vancomycin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ).

4648899-8 | Breast Cancer Female
Adverse event was reported on Apr 12, 2005 by a Female patient taking Duricef (View Usage) (Dosage: 500 Mg) . Location: , 70 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer female. During the same period patient was treated with DORYX (100 Mg, Oral) (View Doryx Review and Doryx Label ), PROVERA (See Image) (View Provera Review and Provera Label ), PREMARIN (0.625 Mg, Oral) (View Premarin Review and Premarin Label ), PREMPRO (0.625 Mg/2.5 Mg, , Oral) (View Prempro Review and Prempro Label ), CEPHALEXIN (CEFALEXIN) CAPSULE (View Cephalexin (cefalexin) Capsule Review and Cephalexin (cefalexin) Capsule Label ). Patient was hospitalized.

4635757-8 | Ascites, Hepatitis
on Mar 28, 2005 Female patient from , 66 years of age, was treated with Duricef (View Usage). Patient had the following side effects: ascites, hepatitis (What is hepatitis?). Duricef dosage: Oral. During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), OXYTETRACYCLINE (View Oxytetracycline Review and Oxytetracycline Label ). Patient was hospitalized.

4630226-3 | Anaphylactic Shock
on Mar 21, 2005 Female patient from , 34 years of age, was diagnosed with nasopharyngitis and was treated with Duricef (View Usage). After Duricef was administered, patient had the following side effects: anaphylactic shock. Duricef dosage: 250 Mg, Tid, Oral. During the same period patient was treated with LOXONIN (LOXOPROFEN SODIUM) (View Loxonin (loxoprofen Sodium) Review and Loxonin (loxoprofen Sodium) Label ), MEDICON (DEXTROMETHORPHAN HYDROBROMIDE) (View Medicon (dextromethorphan Hydrobromide) Review and Medicon (dextromethorphan Hydrobromide) Label ).